regiones capitis (머리, 두부
| receptors, peptide | Cell surface receptors that bind peptide messengers with high affinity and regulate intracellular signals which influence the behaviour of cells. (12 Dec 1998) |
|---|---|
| receptors, phencyclidine | Specific sites or molecular structures on cell membranes or in cells with which phencyclidine reacts or to which it binds to elicit the specific response of the cell to phencyclidine. Studies have demonstrated the presence of multiple receptor sites for pcp. These are the pcp/sigma site, which binds both pcp and psychotomimetic opiates but not certain antipsychotics, and the pcp site, which selectively binds pcp analogs. (12 Dec 1998) |
| receptors, pituitary hormone | Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. (12 Dec 1998) |
| receptors, pituitary hormone-regulating hormone | Cell surface receptors that bind the hypothalamic hormones regulating pituitary cell differentiation, proliferation, and hormone synthesis and release, including the pituitary-releasing and release-inhibiting hormones. The pituitary hormone-regulating hormones are also released by cells other than hypothalamic neurons, and their receptors also occur on non-pituitary cells, especially brain neurons, where their role is less well understood. Receptors for dopamine, which is a prolactin release-inhibiting hormone as well as a common neurotransmitter, are not included here. (12 Dec 1998) |
| receptors, platelet-derived growth factor | Specific molecular sites or structures on cell membranes that react with platelet-derived growth factor, its analogs, or antagonists, to elicit or to inhibit the specific response of the cell to this factor. Pdgf binds with different affinities and specificities to two structurally related receptors, the alpha-receptor and the beta-receptor. Both of these receptors are transmembrane proteins with an intracellular, ligand-stimulatable protein kinase domain. (12 Dec 1998) |
| receptors, polymeric immunoglobulin | Specialised fc receptors (receptors, fc) for polymeric immunoglobulins, which mediate transcytosis of polymeric IgA and IgM into external secretions. They are found on the surfaces of epithelial cells and hepatocytes. After binding to IgA, the receptor-ligand complex undergoes endocytosis, transport by vesicle, and secretion into the lumen by exocytosis. Before release, the part of the receptor (secretory component) that is bound to IgA is proteolytically cleaved from its transmembrane tail. (12 Dec 1998) |
| receptors, presynaptic | Neurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed autoreceptors. (12 Dec 1998) |
| receptors, progesterone | Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, a and b. Both are induced by oestrogen and have short half-lives. (12 Dec 1998) |
| receptors, prolactin | Labile proteins on or in prolactin-sensitive cells that bind prolactin initiating the cells' physiological response to that hormone. Mammary casein synthesis is one of the responses. The receptors are also found in placenta, liver, testes, kidneys, ovaries, and other organs and bind and respond to certain other hormones and their analogs and antagonists. This receptor is related to the growth hormone receptor. (12 Dec 1998) |
| receptors, prostaglandin | Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behaviour of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin d2 (dp receptors), prostaglandin e2 (ep1, ep2, and ep3 receptors), prostaglandin f2-alpha (fp receptors), and prostacyclin (ip receptors). (12 Dec 1998) |
| receptors, prostaglandin e | Cell surface receptors which bind prostaglandins with a high affinity and trigger intracellular changes which influence the behaviour of cells. Prostaglandin e receptors prefer prostaglandin e2 to other endogenous prostaglandins. They are subdivided into ep1, ep2, and ep3 types based on their effects and their pharmacology. (12 Dec 1998) |
| receptors, purinergic | Cell surface proteins that bind purines with high affinity and trigger intracellular changes which influence the behaviour of cells. The best characterised classes of purinergic receptors in mammals are the p1 receptors, which prefer adenosine, and the p2 receptors, which prefer ATP or ADP. (12 Dec 1998) |
| receptors, purinergic p1 | A class of cell surface receptors that prefers adenosine to other endogenous purines. Purinergic p1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (a1 and a2, or ri and ra). The methylxanthines, e.g., caffeine, bind to these receptors, but also have other unrelated effects. (12 Dec 1998) |
| receptors, purinergic p2 | A class of cell surface receptors for purines that prefer ATP or ADP over adenosine. P2 purinergic receptors are widespread in the periphery and in the central and peripheral nervous system. Subtypes have been proposed, usually designated p2 x, y, z, and t. P2x receptors may mediate fast synaptic transmission by ATP. The ADP-preferring p2t receptors in platelets stimulate aggregation. (12 Dec 1998) |
| receptors, retinoic acid | Proteins in the nucleus or cytoplasm that specifically bind retinoic acid or retinol and trigger changes in the behaviour of cells. Retinoic acid receptors, like steroid receptors, are ligand-activated transcription regulators. Several types have been recognised. (12 Dec 1998) |
Synonyms : 5-HT(1B) Receptor, 5-HT(1Dbeta) Receptor, 5-HT1B Receptor, 5-HT1Dbeta Receptor, 5-Hydroxytryptamine 1B Receptor, 5-Hydroxytryptamine 1B Receptors, Receptor, 5-Hydroxytryptamine 1B, Receptor, Serotonin Type 1Dbeta, Serotonin 1D Beta Receptor, 5 HT1B Receptor
Synonyms : 5-HT(1D) Receptor, 5-HT(1Dalpha) Receptor, 5-HT1D Receptor, 5-HT1Dalpha Receptor, 5-Hydroxytryptamine1D Receptor, Receptor, Serotonin 1D, Receptor, Serotonin 1Dalpha, Serotonin 1D Alpha Receptor, Serotonin 1D Receptors, Serotonin 1Dalpha Receptor
Synonyms : 5-HT(2A) Receptor, 5-HT2A Receptor, Receptor, Serotonin 2A, Serotonin 2A Receptors, 2A Receptor, Serotonin, 2A Receptors, Serotonin, 5 HT2A Receptor, Receptor, 5-HT2A, Receptors, Serotonin 2A
Synonyms : (5-HT)2B Receptors, 5-HT2B Receptor, 5-Hydroxytryptamine 2B Receptor, Receptor, Serotonin 2B, Serotonin 2B Receptors, 2B Receptor, 5-Hydroxytryptamine, 2B Receptor, Serotonin, 2B Receptors, Serotonin, 5 HT2B Receptor, 5 Hydroxytryptamine 2B Receptor
Synonyms : 5-HT(2C) Receptor, 5-HT2C Receptor, 5-Hydroxytryptamine Type 2C Receptor, 5-Hydroxytryptamine Type 2C Receptors, Receptor, 5-Hydroxytryptamine Type 2C, 2C Receptor, Serotonin, 5 HT2C Receptor, 5 Hydroxytryptamine Type 2C Receptor, Receptor, 5-HT2C
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
레바윈정 - 새창
|
대원제약 |
A12804131 | Rebamipide | 전문의약품 | 삭제 |
|
뮤코트라정 - 새창
|
대웅제약 |
A04304101 | Rebamipide | 전문의약품 | 급여 |
|
뮤스타정 - 새창
|
고려제약 |
A15902151 | Rebamipide | 전문의약품 | 급여 |
|
레바핀정100mg - 새창
|
동화약품공업 |
A05705351 | Rebamipide | 전문의약품 | 급여 |
|
라미스타정 - 새창
|
진양제약 |
A10703501 | Rebamipide | 전문의약품 | 급여 |
|
근화레바미피드정 - 새창
|
근화제약 |
A07208311 | Rebamipide | 전문의약품 | 급여 |
|
레바코스정 - 새창
|
케이엠에스제약 |
A32202501 | Rebamipide | 전문의약품 | 삭제 |
|
레바민정 - 새창
|
삼아제약 |
A06103391 | Rebamipide | 전문의약품 | 급여 |
|
레드페론캅셀 - 새창
|
진양제약 |
A10751811 | Sodium ferric gluconate complex | 일반의약품 | 삭제 |
|
레드로프시럽 - 새창
|
한국넬슨제약 |
A18401511 | Levodropropizine | 전문의약품 | 급여 |
| refrigerate |
preserve by chilling; "many foods must be refrigerated or else they will spoil" cool or chill in or as if in a refrigerator; "refrigerate this medicine"
출처: wordnet.princeton.edu/perl/webwn
|
|---|---|
| recirculation |
circulation again
출처: wordnet.princeton.edu/perl/webwn
|
| recoil |
flinch: draw back, as with fear or pain; "she flinched when they showed the slaughtering of the calf" backfire: come back to the originator of an action with an undesired effect; "Your comments may backfire and cause you a lot of trouble" the backward jerk of a gun when it is fired bounce: spring back; spring away from an impact; "The rubber ball bounced"; "These particles do not resile but they unite after they collide" a movement back from an impact kick back: spring back, as from a forceful thrust; "The gun kicked back into my shoulder"
출처: wordnet.princeton.edu/perl/webwn
|
| regime |
government: the organization that is the governing authority of a political unit; "the government reduced taxes"; "the matter was referred to higher authorities" regimen: (medicine) a systematic plan for therapy (often including diet)
출처: wordnet.princeton.edu/perl/webwn
|
| repositioning |
the act of placing in a new position
출처: wordnet.princeton.edu/perl/webwn
|
| RE | informal usage attributing authenticity |
|---|---|
| RE | any rational or irrational number |
| RE | the Christian doctrine that the body of Christ is actually present in the Eucharist |
| RE | property consisting of houses and land |
| RE | the main memory in a virtual memory system |
| RE | informal usage attributing authenticity |
| RE | an ancient form of tennis played in a four-walled court |
| RE | informal usage attributing authenticity |
| RE | (computer science) the time it takes for a process under computer control to occur |
| RE | the practical world as opposed to the academic world |
| RE | the business of selling real estate |
| RE | (computer science) of or relating to computer system that update information at the same rate they receive information |